spacer
home > pmps > winter 2001 > the latest developments in the scottish biotechnology industry
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Latest Developments in the Scottish Biotechnology Industry

Ardana Bioscience, the Edinburgh-based pharmaceutical company that specialises in reproductive health, and its Chief Executive Officer, Simon Best, have scooped two biotechnology industry awards. Ardana was voted 'Best New Biotechnology Company 2001' by its peers in the Scottish life sciences community, and Simon Best was also recognised individually for his significant contribution to the sector.


Simon Best was previously CEO of Roslin Bio-Med where he led the merger of Roslin Bio-Med with Geron Corporation, a leader in stem cell technology. In 1999, he was selected as a Global Leader for Tomorrow by the World Economic Forum and was awarded the title 'Science and Technology Venturer of the Year' by the Financial Times, British Venture Capital Association and Cartier.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Patricia Lobo, Editor of PMPS
spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Francine Lane Recipient of 2019 DIA Global Inspire Award

JERSEY CITY – March 21, 2019 – Francine Lane, TrialScope Vice President of Global Transparency, has received a 2019 Global Inspire Award from the Drug Information Association (DIA). Lane, chair of the DIA’s Clinical Trial Disclosure Community, and Robert Paarlberg, past chair, are co-recipients of the Community Engagement Award. The award recognizes DIA community chairs for consistently driving engagement while advancing knowledge and thought leadership within their membership communities.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement